Cell Biology Quiz: Proteasome And Ubiquitin
20 questions · exam conditions
0:00
Proteasome And UbiquitinQuestion 1 of 20

A researcher observes that a protein normally degraded within 2 hours accumulates to abnormally high levels when cells are treated with MG132. However, when the same cells are treated with cycloheximide (which blocks protein synthesis), the protein levels remain elevated even after MG132 removal. What is the most likely explanation for this observation?

MG132 directly inhibits the ubiquitin-activating enzyme, preventing ubiquitin conjugation to target proteins permanently
The proteasome inhibitor MG132 blocks protein degradation, but without new protein synthesis, existing accumulated proteins cannot be processed
MG132 causes irreversible damage to the 26S proteasome complex, requiring new proteasome subunit synthesis for restoration of function
The target protein becomes resistant to ubiquitination after MG132 treatment due to conformational changes in its lysine residues
Cycloheximide prevents synthesis of new ubiquitin molecules needed for the degradation of accumulated proteins after MG132 removal
← Back to quizzes

Cell Biology Quiz

Cell Biology Quiz: Proteasome And Ubiquitin

Practice Proteasome And Ubiquitin in Cell Biology with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Proteasome And Ubiquitin, giving you a quick way to practice the rules, question types, and explanations that matter most for Cell Biology.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

A researcher observes that a protein normally degraded within 2 hours accumulates to abnormally high levels when cells are treated with MG132. However, when the same cells are treated with cycloheximide (which blocks protein synthesis), the protein levels remain elevated even after MG132 removal. What is the most likely explanation for this observation?

  1. MG132 directly inhibits the ubiquitin-activating enzyme, preventing ubiquitin conjugation to target proteins permanently
  2. The proteasome inhibitor MG132 blocks protein degradation, but without new protein synthesis, existing accumulated proteins cannot be processed (correct answer)
  3. MG132 causes irreversible damage to the 26S proteasome complex, requiring new proteasome subunit synthesis for restoration of function
  4. The target protein becomes resistant to ubiquitination after MG132 treatment due to conformational changes in its lysine residues
  5. Cycloheximide prevents synthesis of new ubiquitin molecules needed for the degradation of accumulated proteins after MG132 removal
Explanation: When analyzing protein degradation experiments, you need to understand how proteasome inhibitors work and what happens when protein synthesis is simultaneously blocked. MG132 is a proteasome inhibitor that prevents the degradation of ubiquitinated proteins by blocking the 26S proteasome. When you treat cells with MG132, proteins that would normally be degraded accumulate because the degradation machinery is inhibited. However, MG132's effects are reversible - once removed, proteasome function should restore and accumulated proteins should be degraded. The key insight comes from the cycloheximide experiment. Cycloheximide blocks new protein synthesis, including synthesis of new proteasome subunits and regulatory proteins. When MG132 is removed in the presence of cycloheximide, proteins remain elevated because the cell cannot synthesize new proteasome components needed to restore full degradative capacity. This supports answer B - the proteasome inhibitor blocks degradation, but without new protein synthesis, the existing accumulated proteins cannot be processed effectively. Answer A is incorrect because MG132 targets the proteasome, not ubiquitin-activating enzymes, and its effects aren't permanent. Answer C overstates the case - MG132 doesn't cause irreversible damage but rather reversible inhibition. Answer D is wrong because MG132 doesn't alter protein structure or ubiquitination capacity. Remember: When interpreting drug experiments, consider both the direct effect of the primary drug and how secondary treatments (like protein synthesis inhibitors) reveal the cellular requirements for recovering normal function.

Question 2

A cell line deficient in a specific E2 ubiquitin-conjugating enzyme shows accumulation of certain substrates but normal degradation of others. Analysis reveals that the accumulated proteins all contain a common sequence motif. What is the most likely explanation for this selective effect?

  1. Different E2 enzymes have specific preferences for substrate proteins based on their amino acid sequences and structural motifs
  2. The deficient E2 enzyme specifically recognizes the common motif and directly ubiquitinates proteins containing this sequence
  3. The common motif is recognized by a specific E3 ligase that requires the deficient E2 enzyme for its ubiquitin transfer activity (correct answer)
  4. Proteins with the common motif are more sensitive to proteasome inhibition caused by loss of the E2 enzyme function
  5. The accumulated proteins normally compete for the deficient E2 enzyme, and loss of competition allows degradation of other substrates
Explanation: When you encounter questions about selective protein degradation defects, focus on the hierarchical organization of the ubiquitin-proteasome system. The key players work in sequence: E1 enzymes activate ubiquitin, E2 enzymes conjugate it, and E3 ligases provide substrate specificity by recognizing target proteins and transferring ubiquitin from E2 to the substrate. The selective accumulation pattern here—where only proteins with a common motif are affected—points to disrupted E2-E3 cooperation. Specific E3 ligases recognize distinct sequence motifs on target proteins, then recruit particular E2 enzymes to complete ubiquitin transfer. When that specific E2 is missing, the E3 ligase recognizing the common motif cannot function, causing those substrates to accumulate while other proteins (degraded by different E2-E3 pairs) remain unaffected. Answer choice A incorrectly suggests E2 enzymes directly recognize substrate sequences, but E3 ligases provide substrate specificity. Answer B makes the same error, proposing direct E2-substrate recognition rather than E3-mediated targeting. Answer D mischaracterizes the problem as general proteasome inhibition affecting motif-containing proteins more severely, but the issue is upstream—these proteins aren't being ubiquitinated in the first place. Remember this hierarchy: E3 ligases determine "what gets tagged" by recognizing specific motifs, while E2 enzymes determine "how the tagging happens" by partnering with particular E3s. Selective degradation defects typically trace back to disrupted E2-E3 partnerships, not direct E2-substrate interactions.

Question 3

In a cell expressing a mutant form of Rpn11 (a deubiquitinating enzyme in the 19S regulatory particle), researchers find that ubiquitinated proteins accumulate at the proteasome but are not degraded efficiently. Which step in the proteasome-mediated degradation pathway is most likely impaired?

  1. Recognition and binding of polyubiquitinated substrates by the proteasome receptor subunits in the regulatory particle
  2. ATP-dependent unfolding of the target protein by the AAA+ ATPases in the 19S regulatory particle
  3. Removal of the polyubiquitin chain from the substrate prior to translocation into the catalytic core (correct answer)
  4. Peptide bond hydrolysis by the threonine proteases in the 20S catalytic core of the proteasome
  5. Threading of the deubiquitinated substrate through the narrow channel leading to the proteolytic chamber
Explanation: When you encounter proteasome questions, focus on the sequential steps of protein degradation: recognition, unfolding, deubiquitination, and proteolysis. The key clue here is that ubiquitinated proteins are accumulating at the proteasome but not being degraded, combined with a defective Rpn11 enzyme. Rpn11 is a critical deubiquitinating enzyme (DUB) located in the 19S regulatory particle. Its primary function is to remove polyubiquitin chains from target proteins just before they enter the 20S catalytic core. Without functional Rpn11, substrates cannot be properly processed for degradation, explaining why ubiquitinated proteins accumulate at the proteasome without being degraded. Answer choice A is incorrect because the proteins are successfully reaching the proteasome, indicating that recognition and binding by receptor subunits is working normally. Answer choice B is wrong because ATP-dependent unfolding by AAA+ ATPases occurs before deubiquitination and would likely prevent substrate accumulation at the proteasome if impaired. Answer choice D is incorrect because the threonine proteases in the 20S core are downstream of deubiquitination - substrates never reach this step due to the Rpn11 defect. The correct answer is C because Rpn11's deubiquitinating activity is essential for removing polyubiquitin chains before substrates can enter the catalytic chamber. Study tip: Remember that proteasome degradation follows a strict order: bind → unfold → deubiquitinate → degrade. When analyzing proteasome mutants, identify which enzyme is defective and map it to the corresponding step in this pathway.

Question 4

A temperature-sensitive mutant of an E2 ubiquitin-conjugating enzyme shows normal ubiquitin transfer activity at 25°C but loses activity at 37°C. When cells expressing this mutant are shifted from 25°C to 37°C, which outcome would be expected after 4 hours?

  1. Immediate degradation of all polyubiquitinated proteins due to loss of protective ubiquitin conjugation activity
  2. Accumulation of long-lived proteins and depletion of short-lived proteins normally targeted for rapid turnover
  3. Complete shutdown of proteasome activity due to lack of substrate recognition signals for the 26S complex
  4. Selective accumulation of proteins normally degraded by autophagy while proteasome substrates remain unaffected
  5. Gradual increase in levels of proteins with short half-lives as existing polyubiquitin chains are consumed (correct answer)
Explanation: When you encounter questions about temperature-sensitive mutations in the ubiquitin-proteasome system, focus on understanding what happens when a key component of the degradation machinery fails. E2 ubiquitin-conjugating enzymes are essential for attaching ubiquitin to target proteins, marking them for proteasome degradation. When this mutant E2 loses activity at 37°C, new proteins can no longer be properly tagged with ubiquitin chains. However, proteins that were already polyubiquitinated at 25°C remain tagged and continue to be degraded by the proteasome. After 4 hours at the restrictive temperature, you'd expect to see accumulation of short-lived proteins (which normally require constant ubiquitination for rapid turnover) while long-lived proteins become depleted from the cellular pool. This matches answer choice B. Answer A is incorrect because existing polyubiquitinated proteins aren't suddenly degraded faster - they continue normal degradation while new tagging stops. Answer C misunderstands proteasome function; the 26S proteasome itself remains active and can still degrade previously tagged substrates - it's the tagging process that's disrupted, not substrate recognition. Answer D confuses degradation pathways; autophagy operates independently of the ubiquitin-proteasome system, so E2 dysfunction wouldn't selectively affect autophagy substrates. Remember that temperature-sensitive mutations create conditional knockouts - the pathway stops working at the restrictive temperature, but existing intermediates in the pathway continue to be processed normally. Focus on what accumulates versus what gets depleted when you analyze these experimental scenarios.

Question 5

Researchers studying a cell line notice that when they deplete ATP levels, polyubiquitinated proteins accumulate in the cytoplasm but are not degraded, even though the 20S proteasome retains its peptidase activity in vitro. What is the most direct explanation for this observation?

  1. ATP depletion prevents the ubiquitin-activating enzyme from forming the high-energy thioester bond with ubiquitin
  2. The 26S proteasome cannot assemble properly without ATP-dependent association of the 19S regulatory particles
  3. ATP is required for the AAA+ ATPases in the 19S particle to unfold substrates for proteasome entry (correct answer)
  4. Polyubiquitin chain formation requires ATP for the activation of E2 and E3 enzymes in the conjugation pathway
  5. ATP depletion causes dissociation of deubiquitinating enzymes from the proteasome, preventing substrate processing
Explanation: When you encounter questions about protein degradation and ATP depletion, focus on the sequential steps of proteasome function and where energy is actually required. The key insight here is distinguishing between proteasome assembly and substrate processing. The researchers observed that polyubiquitinated proteins accumulate without degradation, even though the 20S proteasome retains peptidase activity. This tells you the catalytic machinery works fine, but something prevents substrate entry into the proteasome. The correct answer is C because the 19S regulatory particle contains AAA+ ATPases that must unfold protein substrates before they can enter the narrow catalytic chamber of the 20S proteasome. Without ATP, these motors cannot perform the mechanical work needed to denature folded proteins, creating a bottleneck where tagged proteins accumulate but cannot be processed. Option A is incorrect because if ubiquitin activation were blocked, you wouldn't see polyubiquitinated protein accumulation—the proteins wouldn't get tagged in the first place. Option B misidentifies the problem as proteasome assembly failure, but the 20S core remains active, indicating the 26S complex can still form. Option D also contradicts the observation of polyubiquitin accumulation, since blocked E2/E3 activity would prevent ubiquitin chain formation entirely. Remember that proteasome function requires ATP at multiple steps, but the most energy-intensive process is substrate unfolding. When you see questions about proteasome dysfunction with intact catalytic activity, suspect the ATP-dependent unfolding machinery first.

Question 6

In an experiment, cells are transfected with a plasmid encoding ubiquitin where all lysines except K63 are mutated to arginines (K63-only ubiquitin). What would be the most likely consequence for proteasome-mediated protein degradation?

  1. Enhanced protein degradation due to increased specificity of K63-linked polyubiquitin chains for proteasome recognition
  2. Normal protein degradation since K63 linkages are the primary signal recognized by the 26S proteasome
  3. Severely impaired protein degradation because K48-linked polyubiquitin chains are the canonical proteasome targeting signal (correct answer)
  4. Redirected protein degradation through autophagy pathways due to altered ubiquitin chain topology and recognition
  5. Complete inhibition of ubiquitin conjugation because K63 cannot form stable polyubiquitin chains with target proteins
Explanation: When you encounter questions about ubiquitin modifications and protein degradation, focus on understanding that different lysine linkages in polyubiquitin chains serve distinct cellular functions. The type of ubiquitin linkage determines the fate of the tagged protein. The 26S proteasome specifically recognizes K48-linked polyubiquitin chains as the canonical signal for protein degradation. In this experiment, creating a K63-only ubiquitin mutant means cells can only form K63-linked chains, not the K48-linked chains required for proteasome targeting. This would severely impair proteasome-mediated protein degradation because the proteasome wouldn't receive its proper recognition signal. Answer A is incorrect because K63-linked chains don't have enhanced specificity for proteasomes—they actually have reduced recognition. The proteasome evolved to bind K48 linkages preferentially. Answer B misidentifies which linkage type proteasomes recognize; K63 linkages are not the primary proteasome signal. Answer D, while mentioning that altered chain topology affects recognition (which is true), incorrectly suggests this would redirect degradation through autophagy. The K63-only mutation would more likely result in accumulation of undegraded proteins rather than efficient alternative pathway activation. K63-linked ubiquitin chains typically function in non-proteolytic processes like DNA repair, immune signaling, and protein trafficking—not proteasomal degradation. Study tip: Remember "K48 = proteasome fate, K63 = signaling state." This simple rhyme helps you recall that K48 linkages target proteins for degradation while K63 linkages usually serve regulatory signaling functions.

Question 7

A researcher discovers that a novel small molecule specifically inhibits the DUB activity of USP14, which is associated with the 19S proteasome. Treating cells with this inhibitor would most likely result in:

  1. Accelerated protein degradation due to stabilization of polyubiquitin chains on proteasome-bound substrates (correct answer)
  2. Accumulation of free ubiquitin monomers in the cytoplasm due to enhanced polyubiquitin chain disassembly
  3. Reduced proteasome activity because substrates cannot be deubiquitinated before entering the catalytic core
  4. Enhanced autophagy as cells compensate for defective proteasome-mediated degradation pathways
  5. Decreased cellular ubiquitin levels leading to impaired protein quality control and stress responses
Explanation: When you encounter questions about deubiquitinating enzymes (DUBs) and the proteasome, focus on understanding how ubiquitin recycling affects the degradation process. USP14 is a DUB that removes ubiquitin from substrates while they're bound to the 19S proteasome but before they enter the catalytic core. Inhibiting USP14's DUB activity would prevent the removal of ubiquitin chains from proteasome-bound substrates. This means polyubiquitin chains remain attached to proteins as they proceed through degradation, leading to accelerated protein breakdown. The stabilized polyubiquitin chains actually enhance the degradation signal rather than interfering with it. This makes option A correct. Option B is wrong because inhibiting USP14 would decrease, not increase, polyubiquitin chain disassembly, leading to fewer free ubiquitin monomers being released. Option C misunderstands the timing - substrates don't need to be completely deubiquitinated before entering the catalytic core; some deubiquitination normally occurs during the process, but it's not required for entry. Option D incorrectly assumes that stabilizing polyubiquitin chains would impair proteasome function enough to trigger compensatory autophagy, when actually the opposite occurs. For proteasome questions, remember that DUBs like USP14 fine-tune degradation rates rather than acting as essential gatekeepers. Inhibiting them typically enhances rather than blocks protein degradation by preventing the recycling of degradation signals.

Question 8

In a pulse-chase experiment, cells are labeled with radioactive amino acids, then chased with excess unlabeled amino acids in the presence of a proteasome inhibitor. After 6 hours, researchers find that some labeled proteins show increased molecular weight on SDS-PAGE gels compared to control conditions. What is the most likely explanation?

  1. Proteasome inhibition causes protein aggregation, leading to cross-linking and apparent molecular weight increases
  2. Accumulated proteins undergo post-translational modifications like phosphorylation that increase their molecular weight significantly
  3. Proteins destined for degradation accumulate with attached polyubiquitin chains, increasing their apparent molecular weight (correct answer)
  4. Proteasome inhibition triggers compensatory protein synthesis, leading to larger protein isoforms being produced
  5. Reduced protein turnover allows time for proper protein folding, which migrates more slowly through polyacrylamide gels
Explanation: When you encounter pulse-chase experiments with proteasome inhibitors, you're dealing with protein degradation pathways and the ubiquitin-proteasome system. The key insight is understanding what happens when normal protein degradation is blocked. In normal conditions, proteins targeted for degradation are tagged with polyubiquitin chains—multiple ubiquitin proteins (each ~8.5 kDa) linked together and attached to the target protein. The proteasome recognizes these chains and degrades the tagged proteins. When you add a proteasome inhibitor, the degradation machinery stops working, but the ubiquitination process continues. This means proteins keep accumulating polyubiquitin tags without being degraded, making them appear larger on SDS-PAGE gels. Option A is incorrect because while protein aggregation can occur with proteasome inhibition, cross-linking wouldn't survive the denaturing conditions of SDS-PAGE, which breaks non-covalent interactions. Option B fails because typical post-translational modifications like phosphorylation add only small molecular weight increases (phosphate groups are ~80 Da), not the substantial increases observed here. Option D is wrong because proteasome inhibition doesn't trigger synthesis of larger protein isoforms—it affects degradation, not transcription or translation of different variants. The correct answer is C: accumulated polyubiquitin chains create the observed molecular weight increases that persist under denaturing gel conditions. Study tip: Remember that ubiquitin chains are covalently attached and survive SDS-PAGE denaturation, unlike protein aggregates. When you see proteasome inhibitors in experiments, always consider the fate of ubiquitinated proteins that can no longer be degraded.

Question 9

Researchers create a cell line expressing a mutant version of Rpn13, a proteasome receptor subunit that normally binds K48-linked polyubiquitin chains. The mutant Rpn13 has reduced affinity for polyubiquitin but retains its ability to interact with other proteasome subunits. Which experimental result would be most consistent with this mutation?

  1. Complete loss of proteasome assembly and formation of free 20S and 19S particles in the cytoplasm
  2. Selective accumulation of highly ubiquitinated proteins while proteins with short ubiquitin chains are degraded normally (correct answer)
  3. Enhanced degradation of all proteasome substrates due to reduced competition for binding sites on the proteasome
  4. Redirection of polyubiquitinated proteins to autophagy pathways, leading to increased autophagic flux in the cells
  5. Global reduction in protein degradation efficiency affecting both highly and weakly ubiquitinated substrates equally
Explanation: When you encounter proteasome function questions, focus on how substrate recognition and binding drive the degradation process. The proteasome degrades proteins marked with K48-linked polyubiquitin chains, and receptor subunits like Rpn13 are crucial for recognizing these tagged substrates. Since the mutant Rpn13 retains its structural interactions with other proteasome subunits but has reduced affinity for polyubiquitin, the proteasome machinery itself remains intact and functional. However, it becomes less efficient at capturing and processing substrates with longer polyubiquitin chains. This creates a selective degradation defect where heavily ubiquitinated proteins (which depend more on strong receptor-polyubiquitin interactions) accumulate, while proteins with shorter ubiquitin tags can still be degraded through weaker interactions or alternative pathways. This matches option B perfectly. Option A is incorrect because Rpn13 mutation wouldn't prevent proteasome assembly since the mutant still interacts normally with other subunits. Option C misses the mark—reduced binding affinity decreases rather than enhances degradation efficiency, and there's no mechanism for "reduced competition" to improve processing. Option D assumes a complete functional bypass to autophagy, but cells don't typically reroute proteasome substrates to autophagy just because one receptor has reduced affinity. The key insight for proteasome questions is that substrate recognition defects create selective, not global, effects. Always consider whether a mutation affects the machinery itself or just its ability to recognize specific substrates—this distinction often determines the experimental outcome.

Question 10

In a biochemical reconstitution experiment, researchers combine purified 20S proteasomes, polyubiquitinated substrate proteins, ATP, and all necessary cofactors, but observe no protein degradation. Addition of which component would be most critical to restore degradation activity?

  1. Free ubiquitin monomers to maintain the cellular ubiquitin pool during the degradation reaction
  2. 19S regulatory particles to provide substrate recognition, unfolding, and deubiquitination activities (correct answer)
  3. E3 ubiquitin ligases to maintain polyubiquitin chain length on substrates during the degradation process
  4. Deubiquitinating enzymes to remove ubiquitin chains and allow substrate entry into the 20S core
  5. Molecular chaperones to assist in proper folding of the 20S proteasome subunits for optimal activity
Explanation: When you encounter proteasome reconstitution experiments, focus on the structural requirements for the 26S proteasome complex. The 20S proteasome is just the catalytic core - it needs regulatory particles to function with polyubiquitinated substrates. The 26S proteasome consists of the 20S catalytic core plus two 19S regulatory particles. While the 20S core contains the proteolytic active sites, it cannot process polyubiquitinated proteins alone. The 19S regulatory particles are essential because they recognize polyubiquitin chains, unfold substrate proteins, remove ubiquitin chains through their deubiquitinating enzymes, and thread the unfolded substrate into the 20S core's narrow entrance channel. Without 19S particles, polyubiquitinated substrates cannot access the proteolytic sites inside the 20S barrel. This explains why adding 19S regulatory particles (B) would restore degradation activity. Option A is incorrect because free ubiquitin monomers aren't required for the initial degradation step - they're released during the process. Option C misunderstands the experimental setup; E3 ligases aren't needed since substrates are already polyubiquitinated. Option D reflects a partial understanding - while deubiquitination is necessary, it's performed by enzymes within the 19S particle, not by separate enzymes that simply remove chains. Remember that proteasome questions often test whether you understand the division of labor: 20S provides catalysis, while 19S provides substrate recognition, processing, and delivery. The complete 26S complex is required for degrading polyubiquitinated proteins in physiological conditions.

Question 11

A graduate student discovers that overexpression of a particular E3 ubiquitin ligase leads to rapid degradation of a tumor suppressor protein, but only when cells are also treated with a kinase inhibitor that blocks a specific phosphorylation site on the tumor suppressor. What is the most likely explanation for this observation?

  1. The kinase inhibitor directly activates the E3 ligase by preventing inhibitory phosphorylation of the ligase itself
  2. Phosphorylation of the tumor suppressor creates a binding site that sequesters the E3 ligase away from its target
  3. The kinase inhibitor enhances proteasome activity, allowing more efficient degradation of ubiquitinated tumor suppressor
  4. Phosphorylation of the tumor suppressor prevents its recognition by the E3 ligase, and dephosphorylation allows ubiquitination (correct answer)
  5. The kinase inhibitor prevents nuclear export of the tumor suppressor, concentrating it where the E3 ligase is active
Explanation: When you encounter questions about protein degradation and post-translational modifications, focus on how phosphorylation regulates protein-protein interactions, particularly between E3 ligases and their substrates. The key insight here is that phosphorylation often acts as a molecular switch that controls whether proteins can interact with each other. In this case, the tumor suppressor protein needs to be in an unphosphorylated state for the E3 ligase to recognize and bind to it. When the kinase inhibitor blocks phosphorylation of the tumor suppressor, it remains dephosphorylated and becomes accessible to the overexpressed E3 ligase, leading to rapid ubiquitination and degradation. This explains why both conditions (E3 overexpression AND kinase inhibition) are required for the observed effect. Answer A is incorrect because the kinase inhibitor affects the tumor suppressor, not the E3 ligase itself. Answer B reverses the mechanism—phosphorylation doesn't create a sequestering site but rather prevents E3 ligase binding directly to the tumor suppressor. Answer C focuses on proteasome activity, but the experiment specifically involves E3 ligase overexpression, suggesting the bottleneck is in the ubiquitination step, not proteasomal degradation. Remember that phosphorylation frequently serves as a protective mechanism for tumor suppressors by preventing their degradation. When studying ubiquitin-proteasome pathways, pay special attention to how post-translational modifications like phosphorylation regulate the recognition between E3 ligases and their substrates—this is a common regulatory mechanism in cell biology.

Question 12

Researchers studying protein degradation in yeast find that deletion of a gene encoding a proteasome-associated DUB results in slower overall protein degradation, even though individual proteasome complexes show normal peptidase activity. Which mechanism best explains this apparent paradox?

  1. The deleted DUB normally removes inhibitory ubiquitin modifications from proteasome subunits that limit their assembly
  2. Without the DUB, polyubiquitin chains become too long and sterically block substrate access to proteasome active sites
  3. The DUB normally recycles ubiquitin from degraded substrates, and its loss depletes the cellular ubiquitin pool over time (correct answer)
  4. Loss of the DUB causes accumulation of partially processed substrates that competitively inhibit proteasome function
  5. The DUB normally activates proteasome peptidase activity through allosteric regulation, independent of its catalytic function
Explanation: When you encounter questions about proteasome function and protein degradation, focus on the complete cycle: ubiquitination, degradation, and ubiquitin recycling. The key insight here is that protein degradation isn't just about breaking down proteins—it's also about maintaining the cellular machinery that makes degradation possible. The correct answer is C because deubiquitinating enzymes (DUBs) play a crucial role in ubiquitin homeostasis. When substrates are degraded by the proteasome, the polyubiquitin chains attached to them must be removed and the ubiquitin molecules recycled back into the free ubiquitin pool. Without this DUB activity, ubiquitin becomes trapped on degraded peptide fragments, progressively depleting the cellular ubiquitin supply. As free ubiquitin becomes scarce, fewer proteins can be properly tagged for degradation, explaining why overall protein degradation slows despite normal proteasome peptidase activity. Answer A is incorrect because proteasome assembly defects would likely affect peptidase activity, which remains normal here. Answer B misunderstands the mechanism—longer polyubiquitin chains typically enhance rather than block proteasome recognition. Answer D suggests substrate accumulation causes competitive inhibition, but this doesn't explain why peptidase activity remains normal while overall degradation decreases. Remember this principle: cellular processes often depend on recycling key components. When you see normal enzyme activity but reduced overall process efficiency, consider whether essential cofactors or building blocks are being depleted rather than the enzyme itself being defective.

Question 13

In an experiment examining proteasome regulation, cells expressing a non-degradable version of a cell cycle inhibitor protein show cell cycle arrest. However, when these same cells are treated with a compound that enhances 20S proteasome assembly, the cell cycle arrest is partially rescued. What does this suggest about the mechanism of action?

  1. The 20S proteasome can degrade the non-degradable inhibitor through an alternative pathway independent of ubiquitination
  2. Enhanced proteasome assembly increases degradation of other cell cycle regulators, allowing bypass of the inhibitor's effects (correct answer)
  3. The compound directly degrades the cell cycle inhibitor through a non-proteasomal mechanism that mimics proteasome enhancement
  4. Increased 20S levels lead to more 26S proteasome formation, enhancing overall degradation capacity for cell cycle proteins
  5. The non-degradable inhibitor titrates away essential cell cycle machinery, and more proteasomes compete for these factors
Explanation: When analyzing proteasome regulation experiments, focus on the distinction between different degradation pathways and how they can compensate for each other. The key insight here is understanding that cells have multiple mechanisms to control protein levels, and enhancing one pathway can sometimes bypass defects in another. The partial rescue when 20S proteasome assembly is enhanced tells us that the compound isn't directly affecting the non-degradable inhibitor itself. Instead, it's working through an indirect mechanism. By increasing overall proteasome activity, the cell can more efficiently degrade other cell cycle regulatory proteins that normally counterbalance the inhibitor. This shifts the cellular equilibrium, allowing the cell cycle to progress despite the persistent presence of the inhibitor. Answer A is incorrect because non-degradable proteins are specifically designed to resist proteasomal degradation regardless of the pathway - even enhanced 20S activity wouldn't overcome this resistance. Answer C misinterprets the mechanism entirely, as the compound specifically enhances proteasome assembly rather than working through a separate degradation pathway. Answer D focuses too narrowly on 26S formation, but the rescue could occur through enhanced 20S activity alone, and the question specifically mentions 20S assembly enhancement. The correct answer is B because it recognizes that cellular regulation involves balanced networks of proteins, and enhancing degradation of other components can compensate for the inability to degrade one specific inhibitor. Remember: in cell biology experiments involving protein degradation, always consider both direct effects on target proteins and indirect effects on the broader regulatory network.

Question 14

Researchers engineer a fluorescent protein fused to a degradation signal (degron) that is rapidly degraded by the proteasome. When they monitor this reporter in live cells, they observe that protein levels oscillate in a regular pattern rather than showing steady degradation. What cellular mechanism most likely accounts for this oscillatory behavior?

  1. Periodic activation and inactivation of the proteasome system in response to cellular energy levels throughout the cell cycle
  2. Oscillating expression of E3 ubiquitin ligases that recognize the degron, coupled with constant protein synthesis of the reporter (correct answer)
  3. Regular cycles of proteasome assembly and disassembly that coordinate with other cellular quality control mechanisms
  4. Periodic depletion and replenishment of the cellular ubiquitin pool during active phases of protein degradation
  5. Cell cycle-dependent changes in nuclear-cytoplasmic distribution affecting the accessibility of the degradation machinery
Explanation: When you encounter questions about protein degradation and oscillatory patterns, focus on the balance between synthesis and degradation rates, and what cellular mechanisms could create periodic changes in this balance. The oscillatory behavior occurs because protein synthesis remains constant while degradation fluctuates periodically. This happens when E3 ubiquitin ligases that recognize the degron are expressed in cycles—when ligase levels are high, the reporter protein gets rapidly ubiquitinated and degraded by the proteasome. When ligase levels drop, degradation slows while synthesis continues, causing protein levels to rise again. This creates the observed oscillatory pattern rather than steady degradation. Let's examine why the other options don't explain this pattern: Choice A suggests proteasome activity cycles with energy levels, but proteasomes don't typically shut down periodically during normal cell cycle progression—they maintain relatively constant activity. Choice C proposes that proteasomes regularly assemble and disassemble, but proteasomes are stable complexes that don't undergo routine cycles of assembly/disassembly under normal conditions. Choice D suggests ubiquitin depletion causes the oscillations, but cells maintain large ubiquitin pools and have mechanisms to prevent depletion—this wouldn't create regular oscillatory patterns. For cell biology questions about protein dynamics, remember that oscillatory behaviors usually result from periodic changes in regulatory proteins (like transcription factors, kinases, or E3 ligases) rather than periodic dysfunction of core cellular machinery. The synthesis-degradation balance is typically controlled at the regulatory level, not by limiting basic cellular resources.

Question 15

A biochemist studying proteasome function discovers that certain polyubiquitinated substrates are degraded more slowly when free ubiquitin levels in the reaction are increased. This counterintuitive result is most likely explained by:

  1. Free ubiquitin competitively inhibits the binding of polyubiquitinated substrates to proteasome receptor subunits (correct answer)
  2. Higher ubiquitin concentrations promote the activity of deubiquitinating enzymes that remove substrate targeting signals
  3. Excess free ubiquitin interferes with the ATP-dependent unfolding mechanism of the 19S proteasome particle
  4. Free ubiquitin binds to and inhibits the catalytic threonine residues in the 20S proteasome active sites
  5. Elevated ubiquitin levels shift the equilibrium toward substrate deubiquitination rather than proteasome commitment
Explanation: When you encounter questions about proteasome function, focus on the multi-step process: substrate recognition, binding, unfolding, and degradation. The key insight here is understanding how competitive inhibition can occur at the substrate recognition level. The counterintuitive result—slower degradation with more free ubiquitin—points to competitive inhibition. Free ubiquitin molecules compete with polyubiquitinated substrates for the same binding sites on proteasome receptor subunits (like Rpn10, Rpn11, and Rpn13). These receptors recognize ubiquitin chains through specific ubiquitin-binding domains. When free ubiquitin is abundant, it occupies these binding sites, preventing polyubiquitinated substrates from accessing the proteasome effectively. This is answer A—a classic case of competitive inhibition where the inhibitor (free ubiquitin) resembles the substrate (polyubiquitin chains). Answer B is incorrect because while deubiquitinating enzymes do remove ubiquitin, their activity isn't directly promoted by higher ubiquitin concentrations in this context. Answer C misrepresents the mechanism—free ubiquitin doesn't interfere with ATP-dependent unfolding by the 19S particle, which occurs after substrate binding. Answer D is wrong because free ubiquitin doesn't bind to or inhibit the catalytic threonine residues in the 20S particle's active sites; these sites are where peptide bonds are cleaved, not where ubiquitin recognition occurs. Remember: proteasome questions often test your understanding of the recognition and binding steps. When you see unexpected inhibition patterns, think about competitive binding at receptor sites rather than direct enzymatic inhibition.

Question 16

In a cell-free degradation assay, researchers find that adding purified Rad23 protein enhances the degradation of certain polyubiquitinated substrates but inhibits degradation when added in excess. What property of Rad23 best explains this biphasic effect?

  1. Rad23 functions as both a proteasome activator at low concentrations and a competitive inhibitor at high concentrations
  2. Rad23 contains both ubiquitin-binding domains and a proteasome-binding domain, allowing it to shuttle substrates to proteasomes (correct answer)
  3. Rad23 has intrinsic deubiquitinating activity that becomes dominant when present in excess over its shuttle factor function
  4. Rad23 stabilizes proteasome assembly at optimal concentrations but causes proteasome aggregation when overexpressed
  5. Rad23 competes with other essential proteasome cofactors for binding sites when present at high concentrations
Explanation: When you encounter questions about protein degradation and the ubiquitin-proteasome system, focus on understanding how shuttle factors work. These proteins act as molecular escorts, binding both to polyubiquitinated substrates and to proteasomes to facilitate substrate delivery. Rad23 is a classic shuttle factor that contains multiple ubiquitin-binding domains (UBL and UBA domains) plus a proteasome-binding domain. At optimal concentrations, Rad23 enhances degradation by efficiently capturing polyubiquitinated substrates and delivering them to proteasomes. However, when Rad23 is present in excess, it can actually inhibit degradation. This happens because excess Rad23 molecules can occupy proteasome binding sites without carrying substrates, or they can bind to substrates without successfully delivering them, effectively sequestering either the proteasomes or the substrates from productive interactions. Answer A incorrectly suggests Rad23 directly activates proteasomes or acts as a competitive inhibitor, but Rad23 doesn't modify proteasome activity directly. Answer C is wrong because Rad23 lacks deubiquitinating activity—it's purely a shuttle factor. Answer D mischaracterizes Rad23's function, as it doesn't affect proteasome assembly or cause aggregation. The biphasic effect (enhancement then inhibition) is a hallmark of shuttle factor behavior and reflects the balance between productive substrate delivery and interference with the degradation machinery when the shuttle factor becomes too abundant. Study tip: Remember that shuttle factors create bell-shaped dose-response curves—optimal at moderate concentrations, but inhibitory at both very low and very high concentrations due to their dual binding properties.

Question 17

A researcher studying stress responses observes that heat shock causes rapid degradation of certain transcription factors, but this degradation is blocked when cells are pre-treated with an inhibitor of protein kinases. Further analysis shows that the transcription factors become polyubiquitinated only after heat shock and kinase activity. What is the most likely sequence of events?

  1. Heat shock activates kinases that phosphorylate E3 ligases, enhancing their ability to recognize and ubiquitinate the transcription factors
  2. Kinase activation leads to phosphorylation of the transcription factors, creating degradation signals (degrons) recognized by E3 ligases (correct answer)
  3. Heat shock causes protein misfolding, and kinases phosphorylate chaperones that recruit E3 ligases to misfolded transcription factors
  4. Stress-activated kinases phosphorylate proteasome subunits, increasing their affinity for polyubiquitinated transcription factors
  5. Heat shock triggers kinase-dependent nuclear import of cytoplasmic E3 ligases that specifically target nuclear transcription factors
Explanation: When you encounter questions about protein degradation and cellular stress responses, focus on the regulatory mechanisms that control when proteins get targeted for destruction. The ubiquitin-proteasome system doesn't randomly degrade proteins—it requires specific signals called degrons that mark proteins for elimination. The experimental evidence points to a clear sequence: heat shock triggers kinase activation, which phosphorylates the transcription factors themselves, creating degradation signals that E3 ligases can recognize. This explains why both kinase activity and heat shock are required for polyubiquitination—the phosphorylation event creates the molecular "tag" that tells the cell "this protein should be degraded now." Let's examine why the other options don't fit the data. Choice A suggests kinases phosphorylate E3 ligases rather than the transcription factors, but this doesn't explain why these specific transcription factors become targets. Choice C proposes that misfolded proteins recruit E3 ligases through phosphorylated chaperones, but the question indicates the transcription factors themselves must be modified (since kinase inhibition prevents their degradation). Choice D focuses on phosphorylating proteasome subunits to increase degradation efficiency, but this wouldn't explain the specificity for certain transcription factors or why polyubiquitination depends on kinase activity. Remember that regulated protein degradation typically involves phosphorylation creating degrons—recognition sequences that E3 ligases bind to. When you see experiments showing that both a stimulus and kinase activity are required for protein degradation, think about phosphorylation-dependent degron formation as the most likely mechanism.

Question 18

In a study of protein quality control, researchers find that a mutant protein that misfolds at elevated temperature is rapidly degraded by the proteasome, but only when molecular chaperones are also present in the reaction. The chaperones alone cannot refold this mutant protein. What role are the chaperones most likely playing in this degradation process?

  1. Chaperones directly recruit E3 ubiquitin ligases to misfolded proteins through specific protein-protein interactions
  2. Chaperones partially unfold the misfolded protein to expose cryptic degradation signals normally buried in the protein interior
  3. Chaperones prevent aggregation of the misfolded protein, keeping it in a soluble form accessible to the degradation machinery (correct answer)
  4. Chaperones activate the proteasome by inducing conformational changes that enhance its peptidase activity toward misfolded substrates
  5. Chaperones compete with proteasomes for misfolded protein binding, and this competition paradoxically enhances degradation efficiency
Explanation: When you encounter questions about protein quality control, focus on the interconnected roles of molecular chaperones and the ubiquitin-proteasome system. The key insight here is understanding what chaperones do when they cannot successfully refold a protein. The correct answer is C because molecular chaperones serve a critical gatekeeping function in protein degradation. When chaperones attempt to refold a misfolded protein but fail (as stated in the question), they don't simply release it. Instead, they keep the misfolded protein in a soluble, monomeric state that prevents it from forming insoluble aggregates. This soluble form is essential because the proteasome can only degrade proteins that are accessible and properly presented to its catalytic chamber. Without chaperones, misfolded proteins would clump together into aggregates that are physically inaccessible to the degradation machinery. Answer A is incorrect because while some chaperones do interact with E3 ligases, the question specifies that degradation occurs in the presence of chaperones even when they cannot refold the protein—this points to a physical role, not recruitment. Answer B is wrong because chaperones don't create degradation signals by partial unfolding; degradation signals (degrons) are sequence-based, not conformational. Answer D is incorrect because chaperones don't directly activate proteasome peptidase activity—the proteasome's catalytic function is constitutive. Remember: chaperones have dual roles in protein quality control—they attempt refolding first, but when that fails, they serve as "molecular bodyguards" that prevent aggregation while facilitating degradation.

Question 19

A graduate student creates a fusion protein consisting of a stable fluorescent protein linked to a minimal degron sequence that targets proteins for proteasome degradation. When expressed in cells, this fusion protein shows much slower degradation than expected based on the degron's known properties. What is the most likely explanation for this observation?

  1. The fluorescent protein domain interferes with E3 ligase recognition of the degron sequence through steric hindrance
  2. The stable structure of the fluorescent protein creates a kinetic barrier to proteasome-mediated unfolding and degradation (correct answer)
  3. Fusion to the fluorescent protein changes the subcellular localization, moving the degron away from its cognate E3 ligase
  4. The fluorescent protein domain titrates away essential degradation factors, reducing overall proteasome system efficiency
  5. Expression of the fusion protein triggers a cellular stress response that globally downregulates proteasome activity
Explanation: When analyzing protein degradation experiments, you need to consider both the recognition steps (E3 ligase binding) and the actual degradation mechanism at the proteasome. This question tests your understanding of how protein structure affects proteasome function. The proteasome requires proteins to be unfolded before they can be threaded through its catalytic chamber and degraded. Fluorescent proteins like GFP are notoriously stable, with tightly folded β-barrel structures that resist unfolding even under denaturing conditions. When fused to a degron-containing protein, this stable domain creates a significant kinetic barrier. The proteasome can recognize and bind the degron-tagged protein normally, but struggles to unfold the stable fluorescent protein domain, dramatically slowing the overall degradation process. This makes option B correct. Option A is wrong because steric hindrance would typically prevent initial E3 ligase binding entirely, not just slow degradation. Option C incorrectly assumes the fusion changes localization - minimal degrons usually don't contain localization signals, and fluorescent proteins are generally cytoplasmic. Option D describes a trans-dominant effect that would require very high expression levels and would affect all proteasome substrates, not just the fusion protein. Remember this key principle: protein degradation has two distinct steps - recognition/ubiquitination and actual proteolysis. When degradation is slower than expected despite proper recognition, look for structural barriers to unfolding rather than targeting defects. Stable protein domains are common culprits in fusion protein experiments.

Question 20

A cell biologist observes that treatment with the proteasome inhibitor bortezomib causes rapid cell death in certain cancer cell lines but not in normal cells. Analysis reveals that cancer cells have higher baseline levels of polyubiquitinated proteins. What is the most likely mechanism underlying this selective toxicity?

  1. Cancer cells have defective DNA repair mechanisms that make them more sensitive to any form of cellular stress
  2. Normal cells can switch to autophagy-mediated protein degradation more efficiently than cancer cells when proteasomes are inhibited
  3. Cancer cells rely more heavily on proteasome-mediated degradation of regulatory proteins for cell cycle progression and survival (correct answer)
  4. Bortezomib specifically targets cancer cell proteasomes while leaving normal cell proteasomes functionally intact
  5. Cancer cells produce more misfolded proteins that require constant proteasome-mediated quality control for cell viability
Explanation: When you encounter questions about selective drug toxicity in cancer versus normal cells, focus on the fundamental differences in cellular dependencies and stress responses between these cell types. The key insight here is that cancer cells exist in a state of heightened cellular stress and depend more heavily on protein quality control systems. The observation that cancer cells have higher baseline levels of polyubiquitinated proteins indicates they're already struggling with protein homeostasis. When proteasomes are inhibited by bortezomib, cancer cells cannot efficiently degrade critical regulatory proteins involved in cell cycle checkpoints, apoptosis control, and survival signaling. This creates a lethal accumulation of damaged or misfolded proteins, pushing already-stressed cancer cells over the edge into death. Answer A is incorrect because while DNA repair defects exist in some cancers, this doesn't explain the specific proteasome-related mechanism or why normal cells are spared. Answer B is wrong because both cell types can activate autophagy, and this compensation mechanism alone doesn't account for the dramatic selectivity observed. Answer D is factually incorrect—bortezomib inhibits proteasomes in both cancer and normal cells equally; the selectivity comes from differential cellular responses, not drug specificity. The correct answer is C because it captures the core principle: cancer cells' greater reliance on proteasome function due to their altered metabolism, rapid proliferation, and existing protein stress makes them selectively vulnerable when this system is disrupted. Remember: selective toxicity questions often hinge on cancer cells' altered dependencies, not drug selectivity itself.